Form 8-K - Current report:
SEC Accession No. 0000950170-25-086155
Filing Date
2025-06-13
Accepted
2025-06-13 16:05:42
Documents
10
Period of Report
2025-06-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K eq-20250612.htm   iXBRL 8-K 50800
  Complete submission text file 0000950170-25-086155.txt   160992

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eq-20250612.xsd EX-101.SCH 27868
12 EXTRACTED XBRL INSTANCE DOCUMENT eq-20250612_htm.xml XML 4704
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 251046494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)